The reaffirmation of a Buy rating and a $12 price target by Chardan Capital, as analyzed by Keay Nakae, is likely to instill confidence among investors and could positively influence Femasys's stock price in the short term. The analyst's continued support suggests a strong belief in the company's value and potential for growth, which can be a significant positive signal to the market.